GSK PLC is a global biopharmaceutical company. Company segments include commercial operations and research and development. It develops cancer drugs for patients, including ovarian cancer, endometrial cancer and multiple myeloma. Its product areas include vaccines, specialized drugs and general medicine. It also endeavors to meet the therapeutic needs not satisfied with patients with respiratory and inflammatory conditions. His vaccine wallet includes more than 20 vaccines that help protect people from a series of diseases and infections, including meningitis, zona and flu, among others. His specialized drugs are also engaged in the development of drugs for respiratory diseases and HIV. His general drugs include inhaled drugs for asthma and chronic obstructive pulmonary diseases, antibiotics and medicines for skin diseases. It develops therapeutic oligonucleotides for chronic hepatitis B and liver steat diseases, as well as for other therapeutic areas outside liver disease.
